Skip to main navigation Skip to search Skip to main content

CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.

Translated title of the contribution: CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.
  • H.H. van Ojik
  • , L. Bevaart
  • , C.E. Dahle
  • , A.B.H. Bakker
  • , J.H.M. Jansen
  • , M.J. van Vugt
  • , J.G.J. van de Winkel
  • , G.J. Weiner

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionCpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.
Original languageUndefined/Unknown
Pages (from-to)5595-5600
Number of pages6
JournalCancer Research
Volume63
Issue number17
Publication statusPublished - 2003

Cite this